294 related articles for article (PubMed ID: 6332683)
41. Immunological activities of muramyl peptides.
Bahr GM; Chedid L
Fed Proc; 1986 Oct; 45(11):2541-4. PubMed ID: 3489642
[TBL] [Abstract][Full Text] [Related]
42. Preparation for hapten help by glucan, muramyl dipeptide, and its L-ala-Glycerol-mycolate derivative.
Leech SH; Di Luzio NR; Leclerc C
J Leukoc Biol; 1985 Aug; 38(2):317-25. PubMed ID: 3861748
[TBL] [Abstract][Full Text] [Related]
43. Comparison of immunomodulatory activities in mice and guinea pigs of a synthetic desmuramyl peptidolipid triglymyc.
Leclerc CD; Audibert FM; Chedid LA; Deriaud EJ; Masihi NK; Lederer E
Infect Immun; 1984 Mar; 43(3):870-5. PubMed ID: 6698611
[TBL] [Abstract][Full Text] [Related]
44. Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice.
Humphres RC; Henika PR; Ferraresi RW; Krahenbuhl JL
Infect Immun; 1980 Nov; 30(2):462-6. PubMed ID: 7439991
[TBL] [Abstract][Full Text] [Related]
45. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
Adam A; Souvannavong V; Lederer E
Biochem Biophys Res Commun; 1978 Nov; 85(2):684-90. PubMed ID: 367370
[No Abstract] [Full Text] [Related]
46. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
[TBL] [Abstract][Full Text] [Related]
47. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
Leclerc C; Juy D; Bourgeois E; Chedid L
Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
[No Abstract] [Full Text] [Related]
48. Synthesis of a biologically active fluorescent muramyl dipeptide congener.
Hiebert CK; Kopp WC; Richerson HB; Barfknecht CF
J Med Chem; 1983 Dec; 26(12):1729-32. PubMed ID: 6644742
[TBL] [Abstract][Full Text] [Related]
49. Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs.
Saiki I; Tanio Y; Yamawaki M; Uemiya M; Kobayashi S; Fukuda T; Yukimasa H; Yamamura Y; Azuma I
Infect Immun; 1981 Jan; 31(1):114-21. PubMed ID: 6971259
[TBL] [Abstract][Full Text] [Related]
50. Adjuvant activity of nocardomycoloyl derivatives of N-acetylmuramyldipeptide in mice and guinea pigs.
Saiki I; Uemiya M; Kusama T; Yamamura Y; Azuma I
Microbiol Immunol; 1980; 24(3):265-9. PubMed ID: 6968020
[No Abstract] [Full Text] [Related]
51. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
Lowy I; Theze J; Chedid L
J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289
[TBL] [Abstract][Full Text] [Related]
52. Activation of macrophages by quinonyl-N-acetylmuramyl dipeptide.
Saiki I; Tokushima Y; Nishimura K; Yamamura Y; Azuma I
Infect Immun; 1983 May; 40(2):622-8. PubMed ID: 6840857
[TBL] [Abstract][Full Text] [Related]
53. Activation of mouse peritoneal adherent cells with N-acyl muramyl dipeptide derivatives.
Nishimura K; Okumura H; Saiki I; Okuyama H; Azuma I
Infect Immun; 1985 Mar; 47(3):665-9. PubMed ID: 3882562
[TBL] [Abstract][Full Text] [Related]
54. Stimulatory effects of muramyl dipeptide and its butyl ester derivative on the proliferation and activation of macrophages in vitro.
Schindler TE; Coffey RG; Hadden JW
Int J Immunopharmacol; 1986; 8(5):487-98. PubMed ID: 3019904
[TBL] [Abstract][Full Text] [Related]
55. Macrophages are stimulated by muramyl dipeptide to induce polymorphonuclear leukocyte accumulation in the peritoneal cavities of guinea pigs.
Nagao S; Nakanishi M; Kutsukake H; Yagawa K; Kusumoto S; Shiba T; Tanaka A; Kotani S
Infect Immun; 1990 Feb; 58(2):536-42. PubMed ID: 2298491
[TBL] [Abstract][Full Text] [Related]
56. The muramyl dipeptide analog GMTP-N-DPG preferentially induces cellular immunity to soluble antigens.
Fast DJ; Vosika GJ
Vaccine; 1997 Nov; 15(16):1748-52. PubMed ID: 9364678
[TBL] [Abstract][Full Text] [Related]
57. Effect of a synthetic adjuvant for inducing anti-tumour immunity.
Kataoka T; Kinomoto M; Takegawa M; Tokunaga T
Vaccine; 1991 May; 9(5):300-2. PubMed ID: 1872013
[TBL] [Abstract][Full Text] [Related]
58. A synthetic adjuvant effective in inducing antitumor immunity.
Kataoka T; Tokunaga T
Jpn J Cancer Res; 1988 Jul; 79(7):817-20. PubMed ID: 3139596
[TBL] [Abstract][Full Text] [Related]
59. The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: evidence of initial target cells for the adjuvant activity.
Sugimura K; Uemiya M; Saiki I; Azuma I; Yamamura Y
Cell Immunol; 1979 Mar; 43(1):137-49. PubMed ID: 313841
[No Abstract] [Full Text] [Related]
60. Chemical modification of the C-6 substituent in the carbohydrate moiety of N-acetylmuramoyl-L-alanyl-D-isoglutamine (MDP), and the immunoadjuvant activity.
Okumura H; Tokushima Y; Saiki I; Azuma I; Kiso M; Hasegawa A
Carbohydr Res; 1983 Oct; 122(1):87-98. PubMed ID: 6652634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
